Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,007,980
-
Share change
-
-358,752
-
Total reported value
-
$5,732,113,437
-
Put/Call ratio
-
43%
-
Price per share
-
$143.30
-
Number of holders
-
302
-
Value change
-
-$45,630,671
-
Number of buys
-
165
-
Number of sells
-
121
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q2 2017
As of 30 Jun 2017,
ABIOMED INC - COMMON STOCK (ABMD) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,007,980 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Palo Alto Investors, LLC, Essex Woodlands Health Ventures, Inc., BROWN CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
302
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.